Trade Mark Journal No.2026/029 17 July 2026
WO0000001926190 (5,35,42)
Office of origin: United States of America
Date of International Registration:7 May 2026
Date of designation in the UK:
7 May 2026
The mark consists of a stylized letter M formed by a folded band. The band features a color gradient from orange on the left, to red in the middle and on the right.
The color(s) orange and red is/are claimed as a feature of the mark.
The mark consists of a stylized letter M formed by a folded band. The band features a color gradient from orange on the left, to red in the middle and on the right.
International priority date claimed: 1 May 2026
(United States of America)
(99799500)
- Class 5
- Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, and inflammatory diseases and conditions.
- Class 35
- New product commercialization services; business consultation and management regarding marketing activities and launching of new products; business consulting, management, and planning services in the field of product commercialization of pharmaceuticals and biotechnology; providing business information in the field of product commercialization of pharmaceuticals and biotechnology.
- Class 42
- Research and development in the field of pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, and inflammatory diseases and conditions; drug discovery services; research and development in the pharmaceutical and biotechnology fields; medical and scientific research information in the field of pharmaceuticals and biotechnology.
MacroGenics, Inc.
Representative: Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C., 1101 K Street, N.W., , 10th Floor, Washington DC 20005, UNITED STATES OF AMERICA